"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
3d agoen
From the article
Conditions : Ascites Hepatic Interventions : Drug: Dapagliflozin Sponsors : Beni-Suef University Recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.